Education grants

Expected Outcome: Projects are expected to contribute to all the following expected outcomes: Effective and innovative methods for gathering, sharing and using large data sets in energy applications for the purpose of training AI models while ensuring privacy and security. Advanced and - wherever possible - open-source AI foundation models to support the digitalisation of the energy system, through improved grid observability, forecasting of supply and demand, advanced storage and renewables integration, demand side flexibility and energy efficiency. Enhanced cooperation, knowledge sharing and interoperability among energy system actors for secure and seamless data exchange. Advanced methodologies for AI model development ensuring that the results are FAIR (Findable, Accessible, Interoperable, Reusable) beyond the project ending, open source and accommodating for technology evolution. Scope: The quality of AI models depends strongly on the amount, quality, and representativeness of the data used for their training. Projects are expected to focus on developing, training and testing AI foundation models, using extensive data sets to accelerate the energy transition in key focus…

Expected Outcome: Projects under this topic will contribute to the following outcomes: Accelerate market expansion for European deep tech startups across EU regions and beyond by fostering collaboration and mutual support among European deep tech startup ecosystem actors; Interconnect top-tier tech startup and scaleup hubs embedded in research, technology and higher education ecosystems; Enable cross-border access to infrastructures, facilities, corporates, investors and talents to deep tech startups and scaleups, including those funded by the European Innovation Council (EIC); Enable more European deep tech startups, including women-led startups and scaleups, to succeed scaling into globally competitive companies; Strengthen less-connected innovation hubs by integrating them into a Europe-wide collaborative network; Boost private and public investment in deep tech ventures established within the participating innovation hubs. Scope: This action builds upon the EU’s strategic vision outlined in the EU Competitiveness Compass [1] , the EIC scaling strategy [2] , and the EU Startup and Scaleup Strategy [3] . It aligns with the objectives of strengthening Europe’s deep tech…

Expected Outcome: Project results are expected to contribute to all of the following expected outcomes: Police Authorities in Europe are empowered with modern, accessible and validated tools, methodologies and training curricula to anticipate and cope with the misuse of new and emerging technologies for criminal purposes, with the aim to facilitate prevention, detection, efficient data access and investigation of criminal offences in a lawful manner and with full respect of fundamental rights, including the right to protection of personal data and to privacy; Reinforced interdisciplinary collaboration at the European level through the establishment of partnerships among technologists, policymakers and Police Authorities, resulting in a holistic understanding of the challenges posed by emerging technologies and in sharing of best practices; Clear guidelines and frameworks are created, including on procedures and rules, that ensure lawful access to data, balancing the needs of security with respect for privacy and that foster a European approach to the related challenges for the police and the judiciary. Scope: New and emerging technologies (e.g., new communication technologies,…

Expected Outcome: Project results are expected to contribute to some or all of the following expected outcomes: Improved skills, tools and training curricula for Police Authorities in Europe and Civil Society Organisations (or Non-Governmental Organisations) to work with at-risk groups to prevent persons from going missing. Those improved skills, tools and training curricula are to take into account European multicultural dimension, as well as legal and ethical rules of operation; Enhanced investigation tools and methodologies for Police Authorities in Europe to tackle cold cases in the context of missing persons, based on modern (forensic) technologies and criminology; Modern training curricula for Police Authorities, their improved cross-border cooperation and enhanced tools and methodologies to tackle new cases of missing persons; Enriched European common approaches applied by Police Authorities in Europe to fight the issue of missing persons relying on the synergy of technology, the latest socio-psychological knowledge learned from cases, as well as field experience of Police Authorities and entities dealing with victims, while fully respecting fundamental rights such as…

Expected Outcome: One or more of the following should be covered: Implementation of guidelines, standardised processes, or manuals – in the EU or multiple EU MS – concerning the most challenging issues, supporting specific stakeholders and sectors addressed by cybersecurity legislation. Develop and implement tools, raise awareness and encourage and facilitate industry uptake, with a focus on SMEs, of conformity assessments of essential cybersecurity requirements for products with digital elements (hardware and software) under the CRA. Support for mechanisms reducing the administrative burden for entities, like single entry point for incident notification. Establish secure communication channels allowing for cooperation and information sharing initiatives. Support the organisation of regular meetings/workshops to identify good practices within specific sectors or emerging areas and facilitate collaborative efforts between different sectors. Support the development of training courses, on the basis of the ECSF and exercises that promote capacity building and internal awareness. Contribution to CR standardisation: Training materials and training actions on cybersecurity certification…

Expected Outcome: Proposals are expected to contribute to all of the following expected outcomes: policy and decision makers at relevant levels are better equipped to incorporate educational, cultural, societal and behavioural insights related to biodiversity – such as business dependencies, vulnerabilities and systemic risks – into future policy development, including through participatory and co-designed approaches; institutional, business, financial and economic actors have better awareness on the systemic effects of their interactions and interdependencies with ecosystems, including international trade, across value chains; the understanding and mapping of cross-actor and cross-sectoral relationships and their associated knowledge production and decision-making pathways are improved; transdisciplinary research communities from natural and social sciences and humanities (SSH), as well as cultural and creative sectors, among others, collaborate to improve understanding on the indirect drivers [1] behind biodiversity-harming practices, identify leverage points and test evidence-based interventions – including in relation to governance, incentives, narratives, norms and power…

Expected Outcome: Project results are expected to contribute to some or all of the following expected outcomes: Improved understanding of links between addictions and crime, including drivers of criminality; Innovative and effective solutions, including training curricula, for Police Authorities in Europe and relevant Civil Society Organisations (or Non-Governmental Organisations) to prevent addictions and related crimes, with a special attention to young people at risk; Evidence-based support to modernising European criminal justice system’s approach when dealing with addiction-related offenses; Novel approaches of collaboration between different stakeholders, primarily Police Authorities in Europe and Civil Society Organisations (or Non-Governmental Organisations), to increase communities’ addiction resilience, security and safety. Scope: A close and complex relationship exists between addictions, such as gambling, drug or alcohol use, and crime (e.g., criminals are often under the influence of drugs while committing crimes, gamblers or drug users commit crimes to pay for their debts or drugs). In this topic, successful proposals are expected to analyse the specific nexus…

Expected Outcome: Support the adoption of market-ready innovative AI-powered cybersecurity solutions, including solutions developed in the framework of EU-supported research and innovation projects. Provide and deploy up to date AI-powered tools and services to organisations (in particular SMEs) to prepare, protect and respond to cybersecurity threats. Integrate AI technologies into cybersecurity processes to improve the security of ICT solutions, including providing innovative approaches to training employees to use AI solutions for cybersecurity. Deployment of cybersecure tools and technologies relying on trustworthy AI; AI driven cybersecurity tools; Integration of tools to protect and secure AI solutions. Objective: To support the market uptake and dissemination of innovative AI-powered cybersecurity solutions (notably in SMEs, possibly using results stemming from Horizon Europe projects or similar) and improve knowledge and auditing of cybersecurity preparedness. SMEs often lack the resources to assess cyber risks, develop cybersecurity strategies and implement solutions, leaving them vulnerable to cyberattacks. The resilience of organisations that fall into this category is…

Expected Outcome: Secure Data Sharing Framework: Develop standardised and encrypted communication mechanisms to facilitate seamless data exchange between civilian and military stakeholders. These mechanisms should align with GDPR and other EU regulatory requirements. Early Warning Systems (EWS): Establish a European-level EWS for cyber and hybrid threats. These systems should integrate real-time monitoring tools and predictive analytics to pre-emptively identify and neutralise cyber and hybrid threats targeting critical infrastructure. Collaborative Training Programmes: Design joint training programmes that incorporate AI and cybersecurity scenarios for both civilian (including law enforcement) and military personnel. These programmes should address sector specific needs and hybrid threat scenarios. Integrated Threat Detection Systems: Deploy unified threat detection systems leveraging AI, ZTA, and Digital Twins for cross-sectoral application, targeting current and emerging cyber and hybrid threats. Cross-Sector Security Standards: Develop harmonised cybersecurity standards for dual-use technologies to ensure interoperability and scalability across EU Member States and propose…

Expected Outcome: Project results are expected to contribute to some or all of the following expected outcomes: Increased understanding of policymakers and relevant security practitioners of the phenomenon of terrorism and lone-actor violence towards citizens in confined places such as schools, in the European context; Terrorist and lone-actor attacks to citizens in confined places such as schools, are prevented in Europe by, e.g., detecting and tackling early signs of isolation and radicalisation, as well as the promotion of a secure and inclusive environment; European schools and other confined places, e.g., places of worship, public administration or other buildings accessible to the public, are provided with state-of-the-art means of ensuring their security; Cooperation between Police Authorities in Europe and relevant staff (in schools, public administration, etc.) is improved. Scope: Citizens in European schools and other confined spaces (e.g., places of worship, public administration and other buildings accessible to the public) increasingly face various forms of terrorism and lone-actor violence. This topic aims at providing such places with solutions for ensuring civil…

Expected Outcome: Depending on the decision of each NCC, one or more of the following should be covered: Network of national initiatives to accelerate the cybersecurity industry and facilitate Access-to-Market. European frameworks for establishing cybersecurity incubators and accelerators. Cybersecurity Community Observatory to inform subsequent policy interventions by the ECCC and NCCs. Matchmaking events to create connections and build trust; platforms and events for Access-to-Finance and Access-to-Market including in the area of dual-use technologies. Strengthened Cybersecurity Community to support the European Cybersecurity Industrial, Technology and Research Competence Centre; Maintained technical registration possibilities for candidates for the Cybersecurity Competence Community; Technical assistance for potential applicants for ECCC calls. Uptake of cybersecurity solutions. Strengthened cybersecurity capacities of stakeholders. Synergetic activities that strengthen the role of NCC. Centralised the many initiatives focusing on raising awareness and work together with other NCCs to support a cross European approach covering education, studies, training courses and awareness…

Spain – Pre-school education services – Contrato de servicio educativo de la Escuela Infantil “Dulcinea” integrada en la Red Pública de Educación Infantil de la Comunidad de Madrid, y situada en la C/ Moraña, 27. C.P. 28915 - Leganés

This funding opportunity announcement (FOA) encourages applications for institutional research career development (K12) programs that propose to support intensive supervised research training and career development experiences for clinician scientists (Scholars) leading to research independence in the area of substance use and substance use disorder research.

Expected Outcome: The types of deliverables are presented in two parts. The first part covers: Enhanced cooperation, preparedness and cybersecurity resilience in the EU; preparedness support services. Threat assessment and risk assessment services. The second part covers: Risk monitoring services Better compliance, coordinated vulnerability disclosure and monitoring Improved skills, via exercises and training courses, organisation of events, workshops. Stakeholder consultations and white papers. Objective: This action covers two actions from the Cyber Solidarity Act, dedicated to the Cybersecurity Emergency Mechanism, namely (1) coordinated preparedness testing of entities operating in sectors of high criticality across the Union and (2) other preparedness actions for entities operating in sectors of high criticality and other critical sectors. Objectives These actions aim to complement and not duplicate efforts by Member States and those at Union level to increase the level of protection and resilience to cyber threats, in particular for critical industrial installations and infrastructures, by assisting Member States in their efforts to improve their preparedness for cyber…

France – Training services – Accord-cadre à bons de commande pour des prestations de formation professionnelle pour le CROUS Bretagne

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes encourages submission of applications proposing to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to elucidate cancer risk and related outcomes (e.g., risk prediction or reduction, survival, or response to treatment, etc.). The goal of this initiative is to address key scientific questions relevant to cancer by supporting the analysis of existing clinical, environmental, surveillance, health services, vital statistics, behavioral, lifestyle, genomic, and molecular profiles data. Applicants are encouraged to leverage and perform innovative analyses of the existing data. Applications may include new research aims that are being addressed with existing data, new or advanced methods of analyses, or novel combinations and integration of datasets that allow the exploration of important scientific questions in cancer research.

Through this Notice of Funding Opportunity, the National Cancer Institute (NCI) seeks research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of DCTD and OHAM. The proposed project must involve at least 1 clinical trial related to the scientific interests of one or more of the following research programs: Cancer Therapy Evaluation Program, Cancer Imaging Program, Cancer Diagnosis Program, Radiation Research Program, Complementary and Alternative Medicine Program and/or the HIV and AIDS Malignancies Research Programs. Applicants may propose to conduct an early phase trial by itself, or in combination with another research aim(s) as appropriate.

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to stimulate translation of scientific discoveries and engineering developments in imaging, data science and/or spectroscopic technologies into methods or tools that address contemporary problems in understanding the fundamental biology, potential risk of development, diagnosis, treatment, and/or disease status for cancer or other disease.

Expected Outcome: Project are expected to contribute to the following outcomes: a sustainable operational model and reference blueprint for a Data Lab for Science linking with the European Open Science Cloud (EOSC) and the Resource for AI Science in Europe (RAISE), enabling researchers to accelerate the uptake of AI in Science; easier access for researchers to large amounts of AI-ready research data, and to associated high-quality data services to seamlessly develop and train AI models for science; and better alignment, interoperability and scaling across countries and disciplines of AI workflows and related services such as data pooling, anonymisation, curation, or synthetic data generation. Scope: Data Labs are introduced in the Data Union Strategy as a connector between AI factories and the Common European Data Spaces, providing specialised services to enable turning data into useable resources for AI training and the development of AI applications such as data pooling, curation, pseudonymisation, and synthetic data generation. A significant number of tools and services within the scope of the Data Lab concept have been developed by research infrastructures and scientific…

Expected Outcome: Enhanced valorisation of intellectual assets, including dormant patents, from universities and public research organisations to support the adoption of green and digital technologies by industry, SMEs and start-ups/spinoffs. Development of entrepreneurial skills and increased involvement of students, researchers, and innovators in the valorisation of research results. Uptake of effective models and tools to facilitate valorisation of unused IP and intellectual assets and access by startups, SMEs, and innovative companies to this untapped knowledge in public research organisations. Scope: Aligned with the European Union's policy priorities, this action will contribute to overcoming the innovation paradox by maximising the impact of public spending in R&I through improved knowledge valorisation practices, and facilitating the uptake of green and digital technologies by start-ups, spinoffs, and innovative SMEs. By unlocking the untapped potential of intellectual assets within universities and public research organisations, and leveraging the creativity of students, researchers, and innovators, the action seeks to improve value creation opportunities deriving from…

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes encourages submission of applications proposing to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to elucidate cancer risk and related outcomes (e.g., risk prediction or reduction, survival, or response to treatment, etc.). The goal of this initiative is to address key scientific questions relevant to cancer by supporting the analysis of existing clinical, environmental, surveillance, health services, vital statistics, behavioral, lifestyle, genomic, and molecular profiles data. Applicants are encouraged to leverage and perform innovative analyses of the existing data. Applications may include new research aims that are being addressed with existing data, new or advanced methods of analyses, or novel combinations and integration of datasets that allow the exploration of important scientific questions in cancer research.

DN Colleges Group (DNCG) invites tenders from suitably qualified and experienced organisations for appointment to a Learner Finder Preferred Supplier List (PSL). The requirement primarily concerns identifying, engaging and recruiting eligible learners for Adult Skills Funded provision across South Yorkshire and Greater Lincolnshire, including online and distance-learning courses. Services will include learner recruitment, initial advice and guidance, eligibility checks, enrolment support, controlled learner handovers and performance reporting. The arrangement also provides scope for additional learner recruitment services relating to classroom-based Adult Skills, Higher Education and 16-19 provision, where offered by the successful suppliers. DNCG intends to appoint up to three suppliers, ranked following a competitive evaluation. The highest-ranked supplier will ordinarily receive the first opportunity to fulfil requirements, with any unmet demand cascading to the next-ranked supplier in accordance with the published arrangements. The contract will operate for an initial three-year period, with options to extend for two further 12-month periods (3 + 1 + 1). Pricing will be based on agreed fees per eligible learner. No minimum expenditure or learner volumes are guaranteed. The full specification, evaluation methodology, contract terms and tender return requirements are contained within the procurement documentation. To access this competition: Registered: Login to https://suppliers.multiquote.com and view the opportunity CA18541. Not registered: Visit https://suppliers.multiquote.com then register and quote CA18541 as the reason for registration. Any queries please contact MultiQuote on 020 3920 8054.

Awarded activities will facilitate the translation of novel recording and modulation technologies that can be used to treat and/or diagnose central nervous system (CNS) diseases and disorders and to better understand the human CNS, from proof of concept up to the stage of readiness for first in human (FIH) studies. Technologies may incorporate any signal modality (e.g., electrical, optical, magnetic, acoustic) or a combination thereof. Diverse team-based applications that integrate appropriate domains of expertise are encouraged.

Expected Outcome: Projects are expected to contribute to the following outcomes: Raised awareness of venture builders’ roles as part of the ecosystem of startup support in research performing organisations, including universities, Research and Technology Organisations and research and technology infrastructures; Upscaling or establishment of venture builders’ roles in research performing organisations; and Enhanced capacity for sharing resources supporting venture building, exchanging best practices and developing skills needed for successful venture building undertakings in research performing organisations, leading to increased commercialisation of research results (from lab to market). Scope: A variety of organisations across Europe support start up and spin off creation, including incubators, accelerators, innovation hubs, science parks and others. Within this ecosystem, venture builders emerge as playing a double role: on the one hand in building the start-up, drawing on innovative ideas and new technologies at very early stage and bringing together the founding team to create the start up; and on the other hand in providing the support needed to enable the start up to launch…

The purpose of this Notice of Funding Opportunity (NOFO) is to advance the development of novel informatics and data science approaches that can help individuals understand and improve their health through actionable insights. NLM seeks applications that further the science of personal health informatics by providing meaningful and actionable insights to individuals through innovative personal health data collection, integration, analysis, and personalized risk assessments and interpretation. Applications seeking to advance the understanding of how informatics tools, systems, and platforms can best present the results, interpretation, and limitations of personalized assessments for the benefit of individuals are encouraged. Applications should include end user engaged approaches and real-world evaluation to inform the design of generalizable, reusable, and scalable personal health informatics tools, systems, and platforms for the benefit of individuals in understanding and improving their health.

The Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program aims to promote broad participation in the biomedical research ecosystem by supporting resource limited organizations to conduct research, enhance the research environment, and increase sponsored programs administration capacity.This program intends to support eligible, domestic organizations with limited research resources and few biomedical doctoral students.

This funding opportunity is part of a suite of NOFOs within the NIH HEAL Initiative to support the development of safe, effective, and non-addictive therapeutics to treat pain. The goal is to encourage initial translational efforts that will support a drug discovery program and advance projects to the point where they meet the entry criteria for the Pain Therapeutics Development Program. The scope will therefore be focused on development of assays to support a distinct testing funnel, screening efforts to identify hits, and initial characterization of hits and potential therapeutic agents (including small molecules, biologics, and natural products).

The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use. This FOA is open to both individual researchers and research teams and includes all areas of research from basic science to clinical and implementation research. All studies must focus on NIH HIV/AIDS Research Priorities: NOT-OD-20-018: UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding.

Ireland – Education and training services – Rehab Group Provision of First Aid and Related Training Services Across the Organisation

The purpose of this Notice of Funding Opportunity (NOFO) is to invite Small Research Grant (R21) applications that propose to study the ethical, legal, and social implications (ELSI) of human genetics and genomics. Applications may propose studies using either single or mixed methods. Direct involvement of key stakeholders where appropriate is encouraged. These applications should be for small research projects, such as those that involve single investigators. Of particular interest are projects that propose normative or conceptual analyses, including focused legal, economic, philosophical, anthropological, or historical analyses of new or emerging issues. This mechanism can also be used for the collection of preliminary data and the secondary analysis of existing data.

The People and Research Scheme offers grants for activities that help people understand and champion the historic environment through, engagement, skills, training, education and heritage project-based posts. It also offers grants for research activities related to the historic environment sector including scientific and technical conservation, surveys and investigations, publication, archiving, toolkits and guidance. https://historicengland.org.uk/advice/grants/what-we-fund/people-activities/ https://historicengland.org.uk/advice/grants/what-we-fund/research-activities/

Competent consultancy companies are hereby invited to tender to design, develop and deliver a minority community support programme, that will be delivered across the Rowallane and Slieve Croob DEAs (District Electoral Areas). The programme will provide participants with an engaging opportunity to explore the stories of migration, emigration, identity and belonging that have shaped Northern Ireland and its communities over generations. Through a combination of interactive workshops, genealogy activities, and a cultural study visit, participants will examine the historical movements of people that have influenced language, traditions, culture and community life, while also reflecting on their own family histories and personal journeys. To access this competition: Registered: Login to https://suppliers.multiquote.com and view the opportunity CA18552. Not registered: Visit https://suppliers.multiquote.com then register and quote CA18552 as the reason for registration. Any queries please contact MultiQuote on 020 3920 8054.

CCS set up a Dynamic Purchasing System (DPS) for a period of 48 months with the extension option of 24 months. A further extension period of 43 months has been implemented. The total duration of this DPS is 9 years and 7 months and the end date is 27 October 2028. Bidders can request to participate for this DPS for its 115 month duration including any extension periods. This DPS is being procured under the Light Touch Regime (LTR), and is subject to limited regulations, in accordance with Regulations 74-76 PCR2015. This DPS provides central government and wider public sector with the opportunity to procure services within the scope of the existing and new Apprenticeship Standards for England (SASE) live Frameworks, Apprenticeships Standards, End Point Assessments (EPAs); and related services via a number of Education and Skills Funding Agency (ESFA) registered suppliers on the Apprenticeship Training Providers (RoATP) Register and or the Register of EPA Organisations (RoEPAO). CCS reserve the right to reduce, extend or terminate the DPS period at any time during its life time; as set out in the terms of the DMP Agreement. Additional information: CCS set up a Dynamic Purchasing System (DPS) for a period of 48 months with the extension option of 24 months. A further extension period of 43 months has been implemented. The total duration of this DPS is 9 years and 7 months and the end date is 27 October 2028. Please be aware the dates input in the 'Contract Start Date' and 'Contract End Date' have been revised to enable the opportunity to remain open on Contracts Finder. The 'Closing Date' input is correct and is a true reflection of the contract end date for RM6102 - Apprenticeship Training Dynamic Marketplace. Please note that the original notice(s) for the RM6102 Apprenticeship Training DPS were published on Tenders Electronic Daily (TED) and Contracts Finder. As access to TED is no longer held this notice has been published on Find a Tender Service (FTS) for transparency. All relevant links can be found within the Contracts Finder notice.

Invitation to Tender for Supply & Delivery of various City & Guilds Training Courses & Certification. Apply via the in-tend procurement portal: https://supplier.in-tend.co.uk/bedford/home

The purpose of this Funding Opportunity (NOFO) is to solicit grant applications to support research on the discovery and development of interventions to prevent and/or treat substance use disorders (SUDs) and overdose, including medications and medical devices to treat co-morbid SUDs. This includes preclinical and clinical research studies that will have high impact and quickly yield the necessary results to advance candidate interventions closer to regulatory approval or clinical adoption. This NOFO will utilize the UG3/UH3 activity code.

The Regional Improvement for Standards and Excellence (RISE) initiative is a programme by the DfE that is central to the goal of raising standards for all children in all schools across the country. RISE forms part of the government’s Opportunity Mission which focuses on breaking down the barriers to opportunity and ending the link between background and success. The RISE grant will provide mandatory targeted intervention to schools that Ofsted have identified as needing to improve which will act as a catalyst for collaboration and improvement. Where appropriate, RISE teams will arrange for a high-quality organisation to work with a school, via its responsible body, with grants available to fund supporting activity.

NLM wishes to accelerate access to, and availability of, secure, complete datasets and computational models that can serve as the basis for transformative biomedical discoveries. Innovative at-scale computational approaches that increase the speed and scope of curation processes are needed for data mining and knowledge discovery from growing quantities of biomedical data being produced from ongoing data science advances.

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on: Courses for Skills Development

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) seeks research project (R01) grant applications describing projects that integrate imaging and fluid-based tumor monitoring (liquid biopsy) assays during cancer therapy in patients to determine the optimal use of those modalities in the characterization of therapy response and/or emergence of resistance.

The purpose of this Notice of Funding Opportunity (NOFO) is to invite research grant applications (R01) for the development and use of current and emerging molecular imaging methods to gain fundamental insights into cancer inflammation in vivo. The motivation for this initiative is that much of current imaging research into the role of inflammation in cancer is largely based on in vitro and ex vivo methods with limited utilization of imaging approaches that could lead to significant new insights relevant to dynamic cancer and inflammation interactions. Utilization of molecular imaging probes in pre-clinical and clinical investigations for precise temporal resolution at the molecular and cellular level are valuable approaches for identification and characterization of in vivo inflammatory cellular physiology in cancers and of molecular changes in response to treatment. This FOA encourages applications that focus on developing integrated imaging approaches to interrogate the role of inflammation in cancer through strong cross-field collaboration between cancer basic science researchers and imaging scientists. These collaborations are expected to advance science and understanding of cancer inflammation interactions.

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to stimulate efforts to translate scientific discoveries and engineering developments into methods or tools that address problems in basic research to understand disease, or in applied research to assess risk, detect, prevent, diagnose, treat, and/or manage disease. The rationale is to deliver new capabilities to meet evolving requirements for technologies and methods relevant to the advance of research and delivery of care in pre-clinical, clinical and non-clinical settings, domestic or foreign, for conditions and diseases within the missions of participating institutes.

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to stimulate efforts to translate scientific discoveries and engineering developments into methods or tools that address problems in basic research to understand disease, or in applied research to assess risk, detect, prevent, diagnose, treat, and/or manage disease. The rationale is to deliver new capabilities to meet evolving requirements for technologies and methods relevant to the advance of research and delivery of care in pre-clinical, clinical and non-clinical settings, domestic or foreign, for conditions and diseases within the missions of participating institutes.

The purpose of this initiative is to support the development of innovative research centers to foster nursing-led programs that promote community-partnered research to address persistent health challenges. Center applications developed in response to this RFA should propose strategies to strengthen the research infrastructure by establishing or expanding centralized research resources in School or College of Nursing (SON/CON), developing and enhancing nurse-led interdisciplinary teams, and building expertise in community-partnered research through conducting pilot research that applies NINR's research lenses. Center strategies should be informed by NINRs mission and should meaningfully engage the community throughout all activities.

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications for support of investigator-initiated studies addressing mechanisms by which bariatric surgery impacts cancer risk, and seeks to draw in talented scientists who study bariatric surgery to investigate its effects on cancer, rather than shorter-term outcomes such as weight loss and diabetes.

The purpose of this Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutionsis to support small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences primarily for undergraduate students, and enhancing the research environment at applicant institutions. Eligible institutions must award baccalaureate science degrees and have received no more than $6 million dollars per year of NIH support (in both direct and F and A/indirect costs) in 4 of the last 7 fiscal years. For institutions composed of multiple schools and colleges, the $6 million funding limit is based on the amount of NIH funding received by all the non-health professional schools and colleges within the institution as a whole. See Part II. Section 3.1 Eligible Organizations for more information.

The purpose of the Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools is to stimulate basic and clinical research in educational institutions that provide baccalaureate or advanced degrees for a significant number of the Nation's research scientists, but that have not been major recipients of NIH support. REAP grants create opportunities for scientists and institutions otherwise unlikely to participate extensively in NIH research programs to contribute to the Nation's biomedical and behavioral research effort. REAP grants are intended to support small-scale research projects proposed by faculty members of eligible, domestic institutions, to expose undergraduate and/or graduate students at health professional schools or graduate schools to meritorious research projects, and to strengthen the research environment of the applicant institution.Eligible institutions must award NIH-relevant baccalaureate or advanced degrees in health professions and have received less than $6 million per year of NIH support (total costs) in 4 of the last 7 fiscal years. In this NOFO, a college is a stand-alone entity and not a component of a university system.

The purpose of this Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions is to support small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences primarily for undergraduate students and enhancing the research environment at applicant institutions. Eligible institutions must award baccalaureate science degrees and have received no more than $6 million dollars per year of NIH support (in both direct and F and A/indirect costs) in 4 of the last 7 fiscal years. For institutions composed of multiple schools and colleges, the $6 million funding limit is based on the amount of NIH funding received by all the non-health professional schools and colleges within the institution as a whole. This Notice of Funding Opportunity (NOFO) supports investigator-initiated mechanistic and/or minimal risk clinical trials addressing the mission and research interests of the participating NIH institutes. For the purpose of this NOFO, minimal risk clinical trials are defined as those that do not require FDA oversight, do not intend to formally establish efficacy, and have low risks to potentially cause physical or psychological harm.

This notice of funding opportunity (NOFO) will support research towards understanding and mitigating the deleterious effects of acute exposure to Ultra-Potent Synthetic (UPS) opioids (e.g., fentanyl, carfentanil, nitazenes) and their combinations (fentanyl and xylazine). This NOFO will also support research on the persistent and/or delayed pathophysiological effects after acute exposure to such agents.

The National Center for Medical Rehabilitation Research (NCMRR) Early Career Research (ECR) Award (R03) is intended to support both basic and clinical research from rehabilitation scientists who are establishing independent research careers. The research must be focused on one or more of the areas within the mission of NCMRR: Applicants are encouraged to refer to the NIH Research Plan on Rehabilitation for strategic priorities (https://www.nichd.nih.gov/newsroom/news/110121-NIH-rehab-plan). The NCMRR ECR Award R03 grant mechanism supports various types of projects including secondary analysis of existing data; small, self-contained research projects; development of research methodology; translational research; outcomes research; and development of new technology. Irrespective of the type of project, the intent of the NCMRR ECR Award R03 is for the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) to obtain sufficient preliminary data for a subsequent R01 application.

This Notice of Funding Opportunity Announcement (NOFO) is designed to encourage and facilitate the entry of investigators to the area of brain imaging research. This NOFO will support both newly independent investigators and established investigators who are seeking to develop and adopt neuroimaging tools and methodologies in their research programs and conduct small "proof-of-concept" studies relevant to substance use disorders and addiction. This NOFO is intended to support Small Research Grant (R03) projects that can be carried out in a short period of time with limited resources.

The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially high-impact research that is sparse or not included in NIDA's current portfolio that has the potential to transform SUD research. The proposed research should: 1. develop, and/or adapt, revolutionary techniques or methods for addiction research or that show promising future applicability to SUD research; and /or 2. test an innovative and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would transform current thinking.

The SuRE program supports research capacity building at eligible higher education institutions by funding investigator-initiated biomedical research inbasic, social, clinical, behavioral, or translational science that falls in the mission areas of the NIH. The purpose of SuRE awards is to provide support for investigator-initiated research at resource-limited institutions by full-time faculty who are not currently funded by any NIH Research Project Grants (RPGs) with the exception of SuRE or SuRE-First awards, to furnish students with high-quality undergraduate and/or graduate research experiences, and to enhance the institutional scientific research culture.

This is a Notice of Intent only. This Task Agreement is being awarded under Cooperative Agreement P15AC00572 which was already awarded under a competitive process. No applications are being accepted at this time

Data science is an important cross-cutting research approach in the 2022 - 2026 NIDA Strategic Plan and increasing the capacity of experts in addiction related data science is critical. The purpose of this Notice is to facilitate the entry of investigators to the area of addiction-related data science, including newly independent data scientists or established investigators seeking to incorporate novel and cutting-edge data science methodologies into their research programs for the first time. Through this opportunity, investigators will propose to apply emerging data science methods to answer critical questions requiring advanced data analytic strategies. Projects should be small in scale and answer specific research questions or provide preliminary data for a larger scale project. Applicants are encouraged to use existing datasets, follow FAIR principles, and, when applicable, attend to ethical concerns in the conduct of research involving human subjects. Ultimately, the aim is to expedite the development of robust research programs focused on the convergence of innovative data science techniques and addiction research, with initial projects serving as precursors for subsequent, more expansive research projects.

The SuRE program supports research capacity building at eligible higher education institutions through funding investigator-initiated biomedical research inbasic, social, clinical, behavioral, or translational science that falls in the mission areas of the NIH. The purpose of SuRE-First awards is to provide support for investigator-initiated research at resource-limited institutions by full-time faculty who have not had any prior independent, peer-reviewed, external research grants, to furnish students with high-quality undergraduate and/or graduate research experiences, and to enhance the institutional scientific research culture.

Awards will be made as cooperative agreements to accredited Minority Serving Institutions (MSIs) partnered with non-profit organizations in the United States that are eligible to apply for this NASA Research Announcement (NRA). The period of performance for an award is up to 2 years. Prospective proposers are requested to submit any questions in writing to NASAMUSIC@nasaprs.com no later than 10 business days before the proposal due date so that NASA will have sufficient time to respond. Proposers to this NRA are required to have the following, no later than the due date: 1) a Data Universal Numbering System (DUNS) number, 2) a valid registration with the System for Award Management (SAM) [formerly known as the Central Contractor Registry (CCR)], 3) a valid Commercial And Government Entity (CAGE) Code, 4) a valid registration with NASA Solicitation and Proposal Integrated Review and Evaluation System (NSPIRES) (this also applies to any entities proposed for sub-awards or subcontracts.) Consult Appendix H Section H.3.1 for more eligibility information. Consult Appendix H Section 2.2 regarding teaming requirements and partnership guidelines. The goal of NASA MUSIC is: to provide strategic effort that will leverage research and contract relationships of MSIs and NASA through relationships developed by non-profit organizations that may include collaboration of subject matter experts and access to NASA research facilities; An effort to improve STEM education and research at MSIs; A funded activity that seeks to build institutional capacity of MSIs; An activity to support long-term sustainability of STEM research at MSIs. MUSIC seeks to address the agency goals and objectives through: Increasing the institutional awareness of NASA competitive resources that can build the capacity of MSIs to offer and conduct STEM undergraduate and graduate research with a focus on NASA opportunities. Assembling MSIs and their stakeholders with common interests, and challenges then provide common tools for MSIs to increase efficiency and optimize resources including opportunities to develop formal and informal partnerships. Connecting MSI administrators and university STEM leaders to cutting-edge initiatives at NASA that can increase interest in securing research and contracting opportunities while supporting NASA’s policy to achieve an Agency-wide goal of providing one percent of total contract value of prime and subcontracting awards to MSIs. https://www.hq.nasa.gov/office/procurement/regs/1826.htm To achieve these goals, MUSIC seeks to increase university program capacity about practical uses of research to drive institution sustainability through the following targets: Advance the understanding of MSIs on how to effectively develop institutional administrative support by competing at the university level for funding opportunities, which will result in successful application to, and management of these funding opportunities (including those at NASA). Extend MSI’s capabilities by: A. Leveraging the MSIs research capabilities with NASA research to develop Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) projects that develop and demonstrate innovative technologies that fulfill NASA needs and have significant potential for successful commercialization. B. Increasing the preparation of undergraduate and graduate science, technology, engineering, and mathematics faculty with opportunities to participate with NASA researchers and missions through grants and contracts. To achieve these goals and objectives, NASA solicits proposals from MSIs to implement the NASA MUSIC; to engage MSIs in authentic STEM experiences related to NASA missions; and to inspire and captivate learners utilizing NASA’s unique assets to develop a keen interest in STEM. Every institution that intends to submit a proposal to this NRA, including the proposed prime award or any partner whether an education institution, other non-profit institutions, and other organizations that will serve as sub-awardees or contractors, must be registered in NSPIRES. Electronic submission of proposals is required by the due date and must be submitted by an authorized official of the proposing organization. Such registration must identify the authorized organizational representative(s) who will submit the electronic proposal. All principal investigators and other participants (e.g. co-investigators) must be registered in NSPIRES regardless of submission system. Potential proposers and proposing organizations are urged to access the system(s) well in advance of the proposal due date(s) of interest to familiarize themselves with its structure and enter the requested information. Electronic proposals may be submitted via the NASA proposal data system NSPIRES or via Grants.gov. Organizations that intend to submit proposals via Grants.gov must be registered 1) with Grants.gov and 2) with NSPIRES. Additional programmatic information for this NRA may develop before the proposal due date. If so, such information will be added as a Frequently Asked Question (FAQ) or formal amendment to this NRA and posted on http://nspires.nasaprs.com. It is the proposer’s responsibility to regularly check NSPIRES for updates to this NRA.

The NIH Small Research Grant Program supports small research projects that can be carried out in a short period of time with limited resources. This program supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. This Notice of Funding Opportunity does not accept applications proposing clinical trial(s).

This is an Annual Program Statement, outlining our funding priorities, the strategic themes we focus on, and the procedures for submitting requests for funding. Purpose of Small Grants: The Austrian-American Partnership Fund (AAPF) is organized to fund projects advancing collaboration and dialogue and expand cooperation between Austria and the United States. AAPF accepts applications for funding for innovative projects that seek to bring American perspectives to Austria or connect Americans and Austrians in the following priority areas: • Promote understanding of U.S. global foreign policy and economic priorities and interests among Austrian publics, particularly young people, and support U.S.-Austrian initiatives that advance these priorities. • Contribute to strengthening U.S.-Austria efforts to combat shared transnational threats, such as terrorism, illegal migration, antisemitism, or drug trafficking. • Enhance understanding of the United States and U.S.-Austrian shared history and celebrate American arts, film, sports, and music, particularly among youth, including in connection with America’s 250th anniversary in 2026. • Highlight American technological and scientific innovation and economic dynamism and create opportunities for U.S.-Austria collaboration in these fields. Proposals will be considered on a rolling basis and subject to the availability of Public Diplomacy funds for Fiscal Year 2026. The selection process can take up to two - three months. ELIGIBILITY The Public Diplomacy Section encourages applications from Austria, European or, U.S.-based organizations and individuals with proven experience of executing programs. Proposals that demonstrate the long-term sustainability of the proposed project will receive priority. The following organizations are eligible to apply: • Not-for-profit organizations, including think tanks and civil society/non-governmental organizations • Public and private educational institutions • Individuals

Skills Bursaries provide grants of up to £1,000 for people seeking to grow their expertise in community heritage work. Open to applicants at any stage of their personal or professional journey, these bursaries can be used for training, mentoring, attending workshops, or other professional development activities related to heritage and community engagement to be determined by you. Offered on a rolling basis, Skills Bursaries are designed to be accessible and responsive, helping to build confidence and capacity across the sector—particularly among those who may not have had access to such opportunities before.

The purpose of this notice of funding opportunity (NOFO) is to provide salary support for exceptional Research Software Engineers (RSEs) that contribute their skills to the development and dissemination of biomedical, behavioral or health related software, tools, and algorithms as well as to the training of prospective users of these tools.

The purpose of this NOFO is to invite Research Project (R01) applications that propose to study the ethical, legal, and social implications (ELSI) of human genetics and genomics. Applications may propose studies using either single or mixed methods. Approaches may include but are not limited to empirical qualitative and quantitative methods, as well as conceptual, legal, and normative analyses. Direct involvement of key stakeholders where appropriate is encouraged. This Notice of Funding Opportunity (NOFO) requires a Plan for Enhancing Diverse Perspectives (PEDP) as part of the application. Applications without a PEDP will not be reviewed.

The National Institutes of Health (NIH) hereby notifies NIH award recipients that funds may be available for revision applications to support the expansion of existing projects and/or programs within the awarding IC identified in the competitive revision Notice of Special Interest (NOSI). Applications for Revisions will be evaluated for scientific and technical merit by (an) appropriate Scientific Review Group(s), in accordance with NIH peer review policy and procedures, using the stated review criteria. Only applications submitted in response to a NOSI published by an NIH Institute or Center will be allowed to apply to this NOFO.

The purpose of this NOFO is to invite Exploratory/Developmental Research Grant (R21) applications that propose to study the ethical, legal, and social implications (ELSI) of human genetics and genomics. Applications may propose studies using either single or mixed methods. Approaches may include but are not limited to empirical qualitative and quantitative methods, as well as conceptual, legal, and normative analyses. Direct involvement of key stakeholders where appropriate is encouraged. Of particular interest are studies that explore the implications of new or emerging genomic technologies or novel uses of genomic information. 

Expected Impact: Projects selected under this call for proposals should aim to achieve one or more of the following outcomes in the field of countering cybercrime and supporting digital investigations: - increasing operational capacity and capabilities of law enforcement and/or judicial authorities, - increasing the availability of technical tools for law enforcement, - increasing awareness on best practices and available solutions as well as building synergies amongst relevant stakeholders will be an asset Objective: (1) developing capacity and expertise of law enforcement and judicial authorities; (2) contributing to the implementation of EU law and strategic documents; (3) fostering cross-border cooperation between law enforcement/judicial authorities and private entities. Scope: Proposals should focus on: Enhancing the operational capacity of law enforcement and/or judicial authorities to investigate cyber-attacks and cyber enabled crime, for instance through specific training, investigative techniques and tools (including for) with a focus on top threat priorities (excluding online child sexual abuse, which is covered by specific calls for proposals) as presented in Europol…

Procurement and Installation of the Fiber Optic Network for the Eleven (11) Last-mile Higher Education Institutions, Connectivity Between the Points of Presence (POPS) and Connection to the Regional Network (IXP)

Training of Teachers and Staff of HEIs in Digital Skills

Supply of Equipment for BdREN Upgradation (Supply, lnstallation, Testing and Commissioning of Campus Network Equipment for KU, KUET, BMU, CVASU and JUST)

Supply and Delivery of Dining Hall Furniture (4,472 Tables and 8,944 Benches) to Selected Secondary Schools in Various Regions in Ghana (2 Lots)

Supply and Delivery of assorted furniture for classrooms (3-seater desks, Teachers' chairs & Tables), ICT & Science Laboratories (tables, chairs & shelves), Multipurpose Halls furniture and Administration Blocks for 72 New Secondary Schools under USEEP

Supply and Delivery of 25,406 Bunk Beds to Selected Secondary Schools in Various Regions in Ghana (3 Lots)

Supply of Equipment for BdREN Upgradation (Supply, Installation, Testing and Commissioning of Campus Network Equipment for CoU, SBAU, JnU and BAU)

Supply, Delivery, Installation and Commissioning of Wi-Fi Routers and Related Goods for 600 universities and TVETs in Eight (8) Lots

The goal of this NOFO is to support applications for novel theory and methods development that enable better understanding of how genetic and non-genetic factors contribute to complex trait variation across individuals, families, and populations. Approaches should be interdisciplinary drawing from the natural and social sciences, account for interdependencies across scales of biological, social, and ecological organization, and make extensive use of theory, modeling, and validation with available large-scale datasets.

Supply and Delivery of 64,900 Mono Desks to Selected Secondary Schools in Various Regions in Ghana (5 Lots)

This Notice of Funding Opportunity (NOFO) aims to support research on interdisciplinary population approaches to increasing awareness of the relationship between alcohol and cancer risk, understanding and changing social norms related to alcohol consumption, developing and/or evaluating alcohol policy approaches, and the development, testing, and implementation of population-level interventions to reduce alcohol-related cancer risk. Applications that address multiple levels of consumption, such as moderate and heavy drinking, are of particular interest, as well as those focusing on alcohol use disorder (AUD) from the perspective of cancer prevention and control.

The Office of Disease Prevention (ODP) and participating National Institutes of Health (NIH) Institutes, Centers, and Offices (ICs) are issuing this R01 to solicit applications to address barriers and facilitators that impede use or uptake of cancer screening and preventive services in populations that experience health disparities.  Interventions should include screening, preventive services, or other healthcare processes, including timely follow-up of abnormal findings, and referral to accessible care. Projects are encouraged to leverage collaborations with community partners and service providers. Interventions should address barriers and facilitators at two or more of the following levels: patient, clinician, healthcare setting, and neighborhood/community. Specific research interests of participating NIH ICs are detailed within.

The goal of this NOFO is to support R21 applications for novel theory and methods development that better delineate how genetic and non-genetic factors contribute to complex trait variation across individuals, families, and populations. Approaches should be interdisciplinary across the natural and social sciences, account for interdependencies across scales of biological, social, and ecological organization, and make extensive use of theory, simulations, and validation using available large-scale datasets

The goal of the proposed funding announcement is twofold, to promote preclinical and patient based studies examining the mechanism(s) through which incretin mimetics (including agonists or antagonists of GLP-1, GIP-1, or dual GLP-1/GIP-1 agents) impact cancer risk, and to draw talented scientists who understand the dynamic changes caused by these agents to investigate the mechanisms of how these agents influence cancer risk rather than shorter term outcomes such as weight loss and diabetes. The data thus far suggests that these agents may increase the risk of some, while decreasing the risk of other obesity related cancers.

Not available

Through this notice of funding opportunity (NOFO), the National Cancer Institute (NCI) invites applications for support of investigator-initiated clinical trials that have the potential to reduce the burden of cancer through improvements in early detection, screening, prevention and interception, healthcare delivery, quality of life, and/or survivorship related to cancer; with such attributes, the proposed studies should also have the potential to improve clinical practice and/or public health. Applications submitted to this NOFO must include studies that meet the National Institutes of Health (NIH) definition of a clinical trial (see NOT-OD-15-015 for details) and provide specific clinical trial information as described in this FOA. This NOFO does not and will not support clinical trials for studies of cancer diagnosis and/or oncologic therapy in patients. The proposed investigator-initiated projects should be related to the programmatic interests of the NCI Division of Cancer Prevention and/or the NCI Division of Cancer Control and Population Sciences.

The purpose of this notice of funding opportunity (NOFO) is to support research on interventions to improve health in Native American (NA) populations. This includes 1) etiologic research, where there is a significant gap in knowledge, that will directly inform intervention development or adaptations, 2) research that develops, adapts, or tests the efficacy or effectiveness of health promotion and disease prevention interventions, 3) research that tests culturally informed treatment or recovery interventions and 4) where a sufficient body of knowledge on intervention efficacy exists, research on dissemination and implementation that develops and tests strategies to overcome barriers to the adoption, integration, scale-up, and sustainability of effective interventions. Existing data suggest that significant acute and chronic disease inequities exist for NA populations. Concurrently, NA populations experience unique sociopolitical, historical, and environmental stressors and risks that may exacerbate health conditions and/or impact the effectiveness of existing solutions to address the conditions. They also possess unique strengths and resiliencies that can mitigate stressors or inform intervention strategies. Through this initiative, intervention and related research is sought to build upon community knowledge, resources, and resilience to test science-based, culturally appropriate solutions to reduce morbidity and mortality through identification and remediation of precursors to diseases and disorders and through culturally informed treatment. Interventions should be designed with a consideration for sustainability within the communities where they are tested, and have the flexibility to be readily adapted, disseminated, and scaled up to other communities where culturally appropriate. For the purposes of this NOFO, NA includes the following populations: Alaska Natives, American Indians (whose ancestral lands fall at least partially within the U.S. main land).

Procurement of: Design and Development of Payout Software, Testing, Training, Hardware Supply and Installation, and Commissioning of the Management Information System (MIS) for the Deposit and Savings Insurance Fund of Tajikistan (DSIFT)

The goal of the proposed funding announcement is twofold, to promote preclinical and patient based studies examining the mechanism(s) through which incretin mimetics (including agonists or antagonists of GLP-1, GIP-1, or dual GLP-1/GIP-1 agents) impact cancer risk, and to draw talented scientists who understand the dynamic changes caused by these agents to investigate the mechanisms of how these agents influence cancer risk rather than shorter term outcomes such as weight loss and diabetes. The data thus far suggests that these agents may increase the risk of some, while decreasing the risk of other obesity related cancers.

Procurement of Battery Energy Storage Systems (BESS) with Energy Management Systems (EMS) and Ancillary Equipment at Kyiv HPP / PSP, Kaniv, Kremenchuk and Seredniodniprovska Hydropower Plants, including related services (training of UHE staff)

Procurement of Next-Generation Firewall, Management, Reporting and Log Software License Renewal, Hardware, Software, Warranty and Maintenance Extension, and Next-Generation Firewall Capacity Upgrade

Construction and Equipping of 2 No. Farmers Field School and Establishment of 4 No. Wet Markets in Taraba State

Retrofitting and Strengthening/Upgrading of Public School Buildings in Preparation for "The Big One" under IBRD Loan No. 9251-PH: Philippines Seismic Risk Reduction and Resilience Project (PSRRRP) - Contract Package 10

RCC Road starting from Teghori Uttarpara main road to H/O Shajahan, Drain high school para main road to H/O saiful, Road teghari main road to chokvolakha main road, Road Goribpur to H/O Jillur, Drain Poura-Toran to Karotoa, R-Sortoly to Goneshpu Shibgonj.

Feed Formulation and Animal Insemination Equipment for support to Makoda Artificial Insemination center and Department of Animal Production Adustech Wudil University - Kano.

Procurement of 5.000 3D Printers

Procurement of Educational Materials and Equipment for Classrooms and STEM Laboratories for Grades 8–9

Hiring of Third Party Validation (TPV) Firm for the Verification of Performance Based Conditions (PBCs)

Expected Outcome: Project results are expected to contribute to the following outcomes: For supported doctoral candidates New research and transferable skills and competences, leading to improved employability and career prospects within and outside academia; New knowledge allowing the conversion of ideas into products and services, where relevant; Enhanced networking and communication capacities with scientific peers, as well as with the general public that will increase and broaden the research and innovation impact. For participating organisations Improved quality, relevance and sustainability of doctoral training programmes and supervision arrangements; Enhanced cooperation and transfer of knowledge between sectors and disciplines; Increased integration of training and research activities between participating organisations; Boosted R&I capacity; Increased internationalisation and attractiveness; Regular feedback of research results into teaching and education at participating organisations. Scope: MSCA Doctoral Networks will implement doctoral programmes, by partnerships of universities, research institutions and research infrastructures, businesses including SMEs, and other…

Hiring of Consulting firm for technical support to strengthen ECE continuous professional development under GRADES-Baluchistan

The Department for Education (DfE) is seeking to appoint, via an expression of interest (EOI), expert panel members to support the development of the Primary Oracy Framework. Although this is a primary framework, this document will include secondary content and may require secondary expertise. The panel members will work with the lead drafter and DfE to produce a document that provides non-statutory guidance to support the effective teaching of oracy in schools. Panel members will have strong theoretical oracy-expertise and/or extensive experience of delivering oracy across the curriculum, in programmes for schools and CPD for teachers and leaders in different education settings. The role of panel member will include: i. providing expertise and experience to support the development of the framework, including on accuracy of content and deliverability of the content. ii. drafting sections/chapters of the framework and/or making contributions to sections/chapters. iii. attending regular meetings with the DfE & lead drafter to contribute to discussions on the scope and content of the document. The panel will provide advice and guidance and reach a consensus on the issues discussed. iv. advising on evidence and examples of best practice in England and internationally. v. providing regular reviews of content and comment on different iterations of the draft framework. vi. commenting on options for a sustainable approach to the delivery of the Primary-Oracy-Framework, taking account of relevant good practice and innovation from the wider sector. vii. supporting the launch of the Primary Oracy Framework, including using their own networks where appropriate. All panel members will operate on a pro-bono basis. However, where travel expenses are incurred by panel members for in-person meetings, the DfE will reimburse panel members. Governance and Quality Assurance The Department will appoint a lead drafter to develop and drafter the Primary Oracy Framework. This will be a pro-bono agreement, & no fees or commercial consideration will be paid by the Department under this agreement. To support transparency and independent challenge, an Expert Panel will be established through an open Expression of Interest process. How to Apply Applicants must review & comply with the requirements, eligibility criteria, and detailed application instructions set out in the attached documentation. Applications should include only the information and supporting evidence specifically requested within the application documents. Failure to follow the application instructions or provide the required information may result in the application not being considered. To be considered, applicants must: 1. Review attached Specification and supporting documents; 2. Complete the official EOI Application Form provided with this opportunity; 3. Submit the completed Application Form (and any requested supporting information) to oracy.FRAMEWORK@education.gov.uk by 4pm 23-10-26

Expected Outcome: This action builds on the MSCA Doctoral Networks 2026 call (HORIZON-MSCA-DN-2026). The project results are expected to contribute to the following outcomes: For supported doctoral candidates: New research and transferable skills and competences in the application of AI in science, leading to improved employability and career prospects within and outside academia; New knowledge allowing the conversion of ideas into products and services, where relevant; Enhanced networking and communication capacities with scientific peers, as well as with the general public that will increase and broaden the research and innovation impact. For participating organisations: Improved quality, relevance and sustainability of doctoral training programmes and supervision arrangements; Enhanced cooperation and transfer of knowledge between sectors and disciplines; Increased integration of training and research activities between participating organisations; Boosted R&I capacity and uptake of AI in science; Increased internationalisation and attractiveness; Regular feedback of research results into teaching and education at participating organisations. Scope: Successful RAISE Doctoral…

Consultancy Services to Review the Technical Specifications and Supervision of Construction and Commissioning of Research and Training Fishing Vessel in Marine Waters of Tanzania for FETA Mbegani, Bagamoyo

Physical and Learning Spaces Coordinator

Development of functionality for microqualifications

Specialist in the Development of Dual Education and Education for Veterans

Facilitator to lead in-country training and support to develop bankable project proposals for mobilising resources for Climate and Disaster risk financing

Procurement of Network Equipment

Procurement of a Wave Generation and Attenuation System and a Frequency Converter for the Experimental Tank at the Admiral Makarov National University of Shipbuilding

Provision of Internet Connectivity (Satelite Network) with 1 year subscription in 15 additional Schools

Provision of 10 KVA Solar Power in 15 Secondary Schools in Yobe State

Provision of 375 Desktops Computer - 25 per sohool, 15 projector with Motorized Projector Screen i.e 1 set Per School for 15 schools and 50 HP LaserJet Printers for 50 Schools

Procurement of Agricultural Equipment for the Precision Farming Laboratory

National Trainings on Survey Solution tool to support data collection from surveys

Conducting the Mid Term Review of the Project (Nat./Int.)

Procurement of projectors for Odesa I.I. Mechnikov National University and Lviv Polytechnic National University

Consulting Service for Integration and Implementation of Digital Literacy in the Competency Based Curriculum (CBC) through Gender Inclusive Strategies

Specialist in International Cooperation and Internationalisation in Higher Education

Communication and training of accounting and audit staff on new requirements and information collection

Hiring of Consultant Firm for Target Group Identification and Audience Analysis

Recruitment of Education and Research Specialist to support the Learning and Evidence Agenda for Regional Collaboration in Eastern and Southern Africa (LEARN-ESA) (P516274)

Hiring of Third-Party Verification Firm for Trigger 1 (Equity): Financial phasing model for more equitable budgetary allocations and to facilitate school-based hiring

Tongatapu 2 (Package 4): Risk Based Schools Works Package

Procurement of an air conditioner for the server room at Odesa I.I. Mechnikov National University

The purpose of this Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative is to encourage applications that will develop and validate novel tools to facilitate the detailed analysis of complex circuits and provide insights into cellular interactions that underlie brain function. The new tools and technologies should inform and/or exploit cell-type and/or circuit-level specificity. Plans for validating the utility of the tool/technology will be an essential feature of a successful application. The development of new genetic and non-genetic tools for delivering genes, proteins and chemicals to cells of interest or approaches that are expected to target specific cell types and/or circuits in the nervous system with greater precision and sensitivity than currently established methods are encouraged. Tools that can be used in a number of species/model organisms rather than those restricted to a single species are highly desired. Applications that provide approaches that break through existing technical barriers to substantially improve current capabilities are highly encouraged.

The purpose of the NIDA Animal Genetics Program is to identify genetic, genomic, and molecular (epi)genetic variants that underlie: 1. Phenotypes associated with addictive behaviors and/or vulnerability to distinct stages along the substance use disorders (SUD) trajectory (e.g. initial/acute use, escalation of use, acquisition of tolerance, dependence, uncontrolled use, abstinence and relapse or recovery); 2. Behaviors associated with SUD (e.g. impulsivity, novelty seeking, delayed discounting, and other genetically-associated phenotypes); and 3. Comorbidities that demonstrate genetic correlations with phenotypes and behaviors linked with SUD (e.g. anxiety, stress, poor maternal care, social defeat, and other paradigms). Applications may examine any type of genomic variant, including single nucleotide variants (SNVs), indels, large and small structural variants, and all types of mobile DNA. NIDA encourages applications that take genomics, multi-omics, and/or data-based approaches that integrate multi-level omics data, delineate gene networks, and/or uncover the function of known or newly discovered genetic or epigenetic variants. Other areas of interest include genomics analysis at the circuit level and the application of neuroscience to genomics studies. NIDA expects these studies to uncover novel mechanisms that contribute to various stages across the SUD trajectory and inform future studies about potential targets and therapeutic strategies for addiction.

Expected Impact: Stimulate interest and increase knowledge of audiences in European films, including specific programmes on film heritage, and other audiovisual works including videogames and immersive content Strengthen pan-European cooperation for innovative audience development and film education projects especially using new digital tools Increase pan-European impact and audience outreach Develop film education projects across European and non-European territories Scope: Projects ensuring pan-European cooperation and innovation, based on a robust needs’ analysis of audiences, especially targeting young audiences, using evidence-based strategies, aiming to: - increase interest in, knowledge of and access to audiences, in particular young ones, to European films including dedicated programmes on film heritage and other audiovisual works, - enhance pan-European impact and audience outreach, - promote and increase the contribution of existing European films and audiovisual works, towards audience development, film education and film literacy. Activities should include audience-oriented events and innovative or cross-border film education initiatives. Cooperation between film…

The purpose of this initiative is to advance the science of minority health and health disparities by supporting research on family health and well-being and resilience. The NIMHD Research Framework recognizes family health, family well-being, and family resilience as critically important areas of research to decrease disparities and promote equity.

The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use. This FOA is open to both individual researchers and research teams and includes all areas of research from basic science to clinical and implementation research. All studies must focus on NIH HIV/AIDS Research Priorities: NOT-OD-20-018: UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding.

Expected Outcome: World-class National Cyber Hubs across the Union, supported by state-of-the-art technology, acting as clearing houses for detecting, gathering and storing data on cybersecurity threats, analysing this data, and sharing and reporting CTI, reviews and analyses, taking into account well-established standards for sharing and automation processes. Threat intelligence and situational awareness capabilities and capacity building supporting strengthened collaboration between cybersecurity actors, including private and public actors. Targeted training courses on the basis of the ECSF to improve the capacity of cyber security roles. Applications for automated notification of private and public actors about compromised or insecure systems Objective: Where a Member State decides to participate in the European Cybersecurity Alert System, it shall designate or, where applicable, establish a National Cyber Hub, a single entity acting under the authority of the Member State. National Cyber Hubs have the capacity to act as a reference point and gateway to other public and private organisations at national level for collecting and analysing information on cyber threats and…

This notice of funding opportunity (NOFO) encourages formative research, intervention development, and pilot-testing of interventions. Primary scientific areas of focus include the feasibility, tolerability, acceptability and safety of novel or adapted interventions that target HIV prevention, treatment or services research for people who use drugs. For the purposes of this NOFO, "intervention" may include behavioral, social, or structural approaches, as well as combination biomedical and behavioral approaches that prevent the acquisition and transmission of HIV infection, or improve clinical outcomes for persons living with HIV.

Objective: This topic targets projects addressing serious social, economic and environmental challenges deriving from the transition towards the EU’s 2030 climate and energy targets and the EU’s 2050 objective of climate neutrality, for the benefit of the EU territories identified in the Territorial Just Transition Plans. The projects must also qualify for a loan by the EIB (or one of its financial intermediaries). Scope: Projects related to a wide range of sustainable investments may be funded, such as: investments in renewable energy and green and sustainable mobility, including the promotion of green hydrogen efficient district heating networks public research digitalisation environmental infrastructure for smart waste and water management sustainable energy, energy efficiency and integration measures, including renovations and conversions of buildings urban renewal and regeneration the transition to a circular economy land and ecosystem restoration and decontamination, taking into account the ‘polluter pays’ principle biodiversity, as well as up-skilling and re-skilling, training, and social infrastructure, including care facilities and social housing. Infrastructure…

The National Institutes of Health (NIH) hereby notify the applicant community that funds may be available for applications based on a presidentially declared disaster under the Stafford Act, a public health emergency declared by the Secretary, HHS, or other local, regional or national disaster. Applications in response to Emergency Notices of Special Interest (NOSIs) will be routed directly to the NIH awarding component signed on to the Emergency NOSI. Only applications submitted in response to an Emergency NOSI published by an IC will be allowed to apply to this NOFO.

The primary purpose of the NIH Mentored Clinical Scientist Research Career Development Awards (K08) program is to prepare qualified individuals for careers that have a significant impact on the health-related research needs of the Nation. This program represents the continuation of a long-standing NIH program that provides support and "protected time" to individuals with a clinical doctoral degree for an intensive, supervised research career development experience in the fields of biomedical and behavioral research, including translational research.

The primary purpose of the NIH Mentored Clinical Scientist Research Career Development Awards (K08) program is to prepare qualified individuals for careers that have a significant impact on the health-related research needs of the Nation. This program represents the continuation of a long-standing NIH program that provides support and "protected time" to individuals with a clinical doctoral degree for an intensive, supervised research career development experience in the fields of biomedical and behavioral research, including translational research.

The purpose of the NIH Independent Scientist Award (K02) is to foster the development of outstanding scientists and enable them to expand their potential to make significant contributions to their field of research. The K02 award provides three to five years of salary support and "protected time" for newly independent scientists who can demonstrate the need for a period of intensive research focus as a means of enhancing their research careers. Each independent scientist career award program must be tailored to meet the individual needs of the candidate.This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial, as part of their research and career development. Applicants not planning an independent clinical trial, or proposing to gain research experience in a clinical trial led by another investigator, must apply to companion FOA

The Office of Disease Prevention (ODP) and participating National Institutes of Health (NIH) Institutes, Centers, and Offices (ICOs) are issuing this notice of funding opportunity (NOFO) seeking applications to test innovative approaches to implementing SBIRT/P for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities. SBIRT/P, (a term used for purposes of this funding announcement), involves screening individuals for risk of ATOD use and misuse, briefly intervening with a conversation about harmful substance use, and referring individuals for treatment or preventive services, as needed.  Proposed research should include prospective tests of SBIRT/P and should leverage collaborations with healthcare and community partners. Specific research interests of participating NIH ICOs are detailed within.  

The purpose of this funding opportunity is to encourage multidisciplinary investigators to submit applications developing exploratory, highly novel new approaches, or innovative applications of existing approaches to measure brain activity, connectivity, genomics, or other aspects across the age spectrum of neurodevelopment. The overarching goal is to extend our understanding of brain development and aging, including studies of the neurodevelopmental origins of later health and disease, by improving repeated measures across longer epochs of the lifespan to better predict outcomes at later ages. . Research can include healthy human participants of any age, specific clinical groups such those with cognitive, motor, or affective regulation challenges, and/or animal research on these domains of function. The studies can focus on longitudinal neuroanatomical or functional changes at any level, including genetics/genomics, single cells, connectomics, neural population activity patterns, and others. This funding opportunity is intended to encourage technological and conceptual innovation through this high risk, high reward funding mechanism to develop highly innovative ideas that either lack preliminary data or need additional preliminary data

The purpose of this funding opportunity is to encourage multidisciplinary investigators to develop new approaches or apply existing approaches in novel ways to measure brain activity, connectivity, genomics, or other aspects across the age spectrum of neurodevelopment. The overarching goal is to extend our understanding of brain development and aging, including studies of the neurodevelopmental origins of later health and disease. Research can include healthy human participants of any age, specific clinical groups such as those with cognitive, motor, or affective regulation challenges, and/or animal research on these domains of function. The studies can focus on longitudinal neuroanatomical or functional changes at any level, including genetics/genomics, single cells, connectomics, neural population activity patterns, and others. This funding opportunity is intended to encourage technological and conceptual innovation to improve repeated measures across longer epochs of the lifespan, to better predict outcomes at later ages.

The purpose of the NIH Midcareer Investigator Award in Patient-Oriented Research (K24) is to provide support to mid-career health-professional doctorates for protected time to devote to patient-oriented research (POR) and to act as research mentors primarily for clinical residents, clinical fellows and/or junior clinical faculty.

The purpose of the Mentored Quantitative Research Career Development Award (K25) is to attract to NIH-relevant research those investigators whose quantitative science and engineering research has thus far not been focused primarily on questions of health and disease. The K25 award will provide support and "protected time" for a period of supervised study and research for productive professionals with quantitative (e.g., mathematics, statistics, economics, computer science, imaging science, informatics, physics, chemistry) and engineering backgrounds to integrate their expertise with NIH-relevant research.This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial, as part of their research and career development. Applicants not planning an independent clinical trial, or proposing to gain research experience in a clinical trial led by another investigator, must apply to companion FOA.

The purpose of the NIH Mentored Patient-Oriented Research Career Development Award (K23) is to support the career development of individuals with a clinical doctoral degree who have made a commitment to focus their research endeavors on patient-oriented research.

The purpose of the NIH Independent Scientist Award (K02) is to foster the development of outstanding scientists and enable them to expand their potential to make significant contributions to their field of research. The K02 award provides three to five years of salary support and "protected time" for newly independent scientists who can demonstrate the need for a period of intensive research focus as a means of enhancing their research careers. Each independent scientist career award program must be tailored to meet the individual needs of the candidate.This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by another investigator. Applicants proposing a clinical trial or an ancillary clinical trial as lead investigator, should apply to the companion FOA

The purpose of the NIH Pathway to Independence Award (K99/R00) program is to increase and maintain a strong cohort of new and talented, NIH-supported, independent investigators. This program is designed to facilitate a timely transition of outstanding postdoctoral researchers with a research and/or clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions. The program will provide independent NIH research support during this transition in order to help awardees to launch competitive, independent research careers.

The purpose of the NIH Mentored Patient-Oriented Research Career Development Award (K23) is to support the career development of individuals with a clinical doctoral degree who have made a commitment to focus their research endeavors on patient-oriented research.

The purpose of the NIH Pathway to Independence Award (K99/R00) program is to increase and maintain a strong cohort of new and talented, NIH-supported, independent investigators. This program is designed to facilitate a timely transition of outstanding postdoctoral researchers with a research and/or clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions. The program will provide independent NIH research support during this transition in order to help awardees to launch competitive, independent research careers.

The purpose of the NIH Midcareer Investigator Award in Patient-Oriented Research (K24) is to provide support to mid-career health-professional doctorates for protected time to devote to patient-oriented research (POR) and to act as research mentors primarily for clinical residents, clinical fellows and/or junior clinical faculty.

This Notice of Funding Opportunity (NOFO) encourages pilot and preliminary research in preparation for larger-scale services research effectiveness trials. Relevant trials may test a wide range of approaches, including interventions, practices, and policies designed to optimize access to, and the quality, effectiveness, affordability and utilization of drug, tobacco, or alcohol use disorder treatments and related services, as well as services for comorbid medical and mental disorder conditions. Relevant approaches may include both those that are novel, and those that are commonly used in practice but lack an evidence base. This NOFO provides resources for assessing the feasibility, acceptability, and utility of these approaches, in addition to usual trial preparation activities.

The purpose of the NIH Mentored Research Scientist Development Award (K01) is to provide support and protected time (three to five years) for an intensive, supervised career development experience in the biomedical, behavioral, or clinical sciences leading to research independence. Although all of the participating NIH Institutes and Centers (ICs) use this support mechanism to support career development experiences that lead to research independence, some ICs use the K01 award for individuals who propose to train in a new field or for individuals who have had a hiatus in their research career because of illness or pressing family circumstances. Other ICs use the K01 to support career development in specific fields.This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Applicants proposing a clinical trial or an ancillary clinical trial as lead investigator, should apply to the companion NOFO.

The purpose of the Mentored Quantitative Research Career Development Award (K25) is to attract to NIH-relevant research those investigators whose quantitative science and engineering research has thus far not been focused primarily on questions of health and disease. The K25 award will provide support and "protected time" for a period of supervised study and research for productive professionals with quantitative (e.g., mathematics, statistics, economics, computer science, imaging science, informatics, physics, chemistry) and engineering backgrounds to integrate their expertise with NIH-relevant research.This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Applicants proposing a clinical trial or an ancillary clinical trial as lead investigator, should apply to the companion FOA ().

The purpose of the NIH Mentored Research Scientist Development Award (K01) is to provide support and protected time (three to five years) for an intensive, supervised career development experience in the biomedical, behavioral, or clinical sciences leading to research independence. Although all of the participating NIH Institutes and Centers (ICs) use this support mechanism to support career development experiences that lead to research independence, some ICs use the K01 award for individuals who propose to train in a new field or for individuals who have had a hiatus in their research career because of illness or pressing family circumstances.

The National Institutes of Health (NIH) hereby notify recipient organizations holding specific types of NIH grants, listed in the full Funding Opportunity Announcement (FOA), that applications for change of recipient organization status, often referred to in this announcement as Successor-In-Interest, may be submitted to this NOFO. Applications for change of recipient organization status are considered prior approval requests (as described in Section 8.1.2.8 of the NIH Grants Policy Statement) and will be routed for consideration directly to the Grants Management Specialist named in the current award.Although successor-in-interest requests may be submitted through this NOFO, there is no guarantee that an award will be transferred to the new organization. All applicants are encouraged to discuss potential requests with the awarding IC before submission.

The purpose of this funding opportunity announcement (FOA) is to invite applications for a broad range of research efforts in computational genomics, data science, statistics, and bioinformatics relevant to one or both of basic or clinical genomic science, and broadly applicable to human health and disease. This FOA supports fundamental genomics research developing innovative analytical methodologies and approaches, early-stage development of tools and software, and refinement or hardening of software and tools of high value to the biomedical genomics community. Work supported under this FOA should be enabling for genomics and be generalizable or broadly applicable across diseases and biological systems. All applications should address how the methods would scale to address increasingly larger data sets.

This Notice of Funding Opportunity (NOFO) will support students at institutions without NIH-funded institutional predoctoral dual-degree training programs. The purpose of the Kirschstein-NRSA, dual-doctoral degree, predoctoral fellowship (F30) is to enhance the integrated research and clinical training of promising predoctoral students, who are matriculated in a combined MD/PhD or other dual-doctoral degree training program (e.g. DO/PhD, DDS/PhD, AuD/PhD, DVM/PhD), and who intend careers as physician/clinician-scientists. Candidates must propose an integrated research and clinical training plan and a dissertation research project in scientific health-related fields relevant to the missions of the participating NIH Institutes and Centers. The fellowship experience is expected to clearly enhance the individual's potential to develop into a productive, independent physician/clinician-scientist. This NOFO is designed specifically for candidates proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial, but does allow candidates to propose research experience in a clinical trial led by a sponsor or co-sponsor.

The purpose of this Notice of Funding Opportunity (NOFO) is to support innovative population-based research that can contribute to identifying and characterizing pathways and mechanisms through which work or occupation influences health outcomes and health status among populations with health and/or health care disparities.

This PAR is being reissued in accordance with the simplified review criteria in effect for application due dates after January 25, 2025. The objective of this funding opportunity is to support non-pharmacological interventions to promote sleep health, reduce sleep health disparities, and examine sleep as a modifiable factor to reduce health disparities for other health outcomes among populations that experience health disparities.

The purpose of this FOA is to facilitate well planned clinical trials across the cancer prevention and control spectrum aimed at improving prevention/ interception, cancer-related health behaviors, screening, early detection, healthcare delivery, management of treatment-related symptoms, supportive care, and the long-term outcomes of cancer survivors. Although the scientific literature or preliminary data may provide the rationale for conducting a clinical trial, investigators often lack critical information about the study population, accrual challenges, intervention, outcome/ endpoints, data/statistical challenges or operational risks necessary to finalize the trial protocol completely. These information gaps can result in multiple protocol changes before and after trial start-up, leading to the need for additional time and expenses that may prevent study completion. Further, the suitability and feasibility of new trial designs, which minimize infrastructure and reduce costs may need to be tested in the context of a particular intervention, at-risk group, symptom or venue. Preparatory studies may fill information gaps and address unknowns, improving trial design and knowledge of trial feasibility and thus saving NCI time and money.

The purpose of this Funding Opportunity Announcement (FOA) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (de-implement) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. All applications must be within the scope of the mission of one of the Institutes/Centers listed above.

The National Institutes of Health (NIH) will award Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants (T32) to eligible, domestic institutions to develop and/or enhance predoctoral and postdoctoral research training, including short-term research training, to help ensure that a highly trained workforce is available to meet the needs of the Nations biomedical, behavioral, and clinical research agenda. Research training programs are expected to incorporate engaging, didactic, research, and career development elements to prepare trainees for careers that will have a significant impact on the health-related research needs of the Nation. Programs proposing only short-term predoctoral research training should not apply to this announcement, but rather to the Kirschstein-NRSA Short-Term Institutional Research Training Grant Program (T35) exclusively reserved for predoctoral, short-term research training.This Funding Opportunity Announcement (FOA) does not allow appointed Trainees to lead an independent clinical trial but does allow them to obtain research experience in a clinical trial led by a mentor or co-mentor.

The purpose of this NOFO is to facilitate well planned clinical trials across the cancer prevention and control spectrum aimed at improving prevention/ interception, cancer-related health behaviors, screening, early detection, healthcare delivery, management of treatment-related symptoms, supportive care, and the long-term outcomes of cancer survivors. Although the scientific literature or preliminary data may provide the rationale for conducting a clinical trial, investigators often lack critical information about the study population, accrual challenges, intervention, outcome/ endpoints, data/statistical challenges or operational risks necessary to finalize the trial protocol completely. These information gaps can result in multiple protocol changes before and after trial start-up, leading to the need for additional time and expenses that may prevent study completion. Further, the suitability and feasibility of new trial designs, which minimize infrastructure and reduce costs may need to be tested in the context of a particular intervention, at-risk group, symptom or venue. Preparatory studies may fill information gaps and address unknowns, improving trial design and knowledge of trial feasibility and thus saving NCI time and money.

This Funding Opportunity Announcement (FOA) encourages the submission of applications that propose to advance research in cancer etiology and early detection biomarkers, utilizing the advantages of the unique biorepository resources of the NCI-sponsored Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial. The PLCO Biorepository offers high-quality, prospectively collected, serial pre-diagnostic blood samples from the PLCO screened arm participants, and a onetime collection of buccal cells from the control arm participants. Available data associated with the biospecimens includes demographic, diet, lifestyle, smoking, screening results, and clinical data. This FOA supports a wide range of cancer research including, but not limited to, biochemical and genetic analyses of cancer risk, as well as discovery and validation of early detection biomarkers. The proposed research project must involve use of PLCO biospecimens; additionally, it should also take advantage of the unique characteristics of the PLCO biospecimens. Research projects that do not involve the use of PLCO biospecimens will not be supported under this FOA.

The NIH Exploratory/Developmental Grant supports exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research.

This Notice of Funding Opportunity (NOFO) encourages applications for research in cancer control and population sciences. The overarching goal is to provide support to promote research efforts on novel scientific ideas that have the potential to substantially advance cancer research in statistical and analytic methods, epidemiology, cancer survivorship, cancer-related behaviors and behavioral interventions, healthcare delivery, and digital health and data science, and implementation science.

The NIH Research Project Grant supports a discrete, specified, circumscribed project in areas representing the specific interests and competencies of the investigator(s). This Parent Notice of Funding Opportunity Announcement requires that at lease 1 clinical trial be proposed. The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions.

The purpose of this Notice of Funding Opportunity (NOFO) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, sustainability, scale-up, and spread of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies (hereafter referred to as evidence-based interventions). Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (de-implement) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. Applications that focus on re-implementation of evidence-based health services that may be disrupted amidst disasters (e.g., pandemics) remain relevant. All applications must be within the scope of the mission of one of the Institutes/Centers listed above.

The purpose of the NCI Pathway to Independence Award (K99/R00) program is to facilitate a timely transition of talented postdoctoral researchers with a research and/or clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions. The program will provide independent NCI research support during this transition in order to help awardees to launch competitive, independent research careers.

This Notice of Funding Opportunity Announcement (NOFO) from the NIH Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative is intended to support establishment of facilities at minority-serving institutions (MSIs) and Institutional Development Award (IDeA)-eligible institutions for scaled production and distribution of brain cell type-specific access and manipulation reagents. Reagents will be initially developed in pilot resource projects for brain cell type-specific access and manipulation across vertebrate species from the BRAIN Initiative Armamentarium project. Awardees under this NOFO will work with the other Armamentarium awardees to manufacture and distribute the resources for use throughout the neuroscience community. It is envisioned that the awardees will work both with the Armamentarium community as well as with the neuroscience research community to optimize the use of new reagents. The types of reagents to be produced and distributed could include but are not limited to viral vectors, nucleic acid constructs, and nanoparticles designed for selective access to and manipulation of brain cell types. Such reagents will enable neuroscientists to probe circuit function with high precision in experimental animals and ex vivo human tissue and cells. Facilities are needed to contribute to the production and distribution of BRAIN Initiative Armamentarium project reagents broadly to neuroscience users.

The purpose of this notice of funding opportunity (NOFO) is to invite applications proposing the innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of drug using behaviors (defined as alcohol, tobacco, prescription and other drug) and related disorders, prevention of drug use and HIV, and health service utilization. This FOA encourages the analyses of public use and other extant community-based or clinical datasets to their full potential in order to increase our knowledge of etiology, trajectories of drug using behaviors and their consequences including morbidity and mortality, risk and resilience in the development of psychopathology, strategies to guide the development, testing, implementation, and delivery of high quality, effective and efficient services for the prevention and treatment of drug abuse and HIV.

The purpose of the NCI Pathway to Independence Award (K99/R00) program is to facilitate a timely transition of talented postdoctoral researchers with a research and/or clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions. The program will provide independent NCI research support during this transition in order to help awardees to launch competitive, independent research careers.

This funding opportunity announcement (FOA) encourages the submission of exploratory/developmental research grant (R21) applications that focus on different aspects of cancer control by modifying behavior, screening, and understanding etiologic factors contributing to the development of cancer, and developing ways to control cancer. The overarching goal is to provide support to promote the early and conceptual stages of research efforts on novel scientific ideas that have the potential to substantially advance population-based cancer research, such as the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of cancer research (epidemiologic, biomedical, behavioral, health care delivery or clinical).

This Notice of Funding Opportunity (NOFO) encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/genetic causes of cancer health disparities. These research project grants will support innovative studies designed to investigate biological/genetic bases of cancer disparities, such as (1) mechanistic studies of biological factors associated with cancer disparities, including those related to basic research in cancer biology or cancer prevention strategies, (2) the development and testing of new methodologies and models, and (3) secondary data analyses. This NOFO is also designed to aid and facilitate the growth of a nationwide cohort of scientists with a high level of basic research expertise in cancer health disparities research who can expand available resources and tools, such as biospecimens, patient derived models, and methods that are necessary to conduct basic research in cancer health disparities.

This initiative will support multi-level and/or multi-domain intervention research to reduce disparities in liver diseases and liver cancer among populations who experience health disparities in the United States (U.S.). This NOFO is being reissued in accordance with the simplified review criteria in effect for application due dates after January 25, 2025.

The Stephen I. Katz Early Stage Investigator Research Project Grant supports an innovative project that represents a change in research direction for an early stage investigator (ESI) and for which no preliminary data exist. Applications submitted to this Notice of Funding Opportunity (NOFO) must not include preliminary data. Applications must include a separate attachment describing the change in research direction.

The purpose of this notice of funding opportunity (NOFO) is to support highly innovative mechanistic research to accelerate precision probiotic interventions using a milestone-driven, biphasic award mechanism, R61/R33 Phased Innovation Award. Specifically, this NOFO solicits applications that will characterize person-specific features affecting probiotic responses to identify subgroups of probiotic responders and to enhance probiotic clinical outcomes. The ultimate goal of this NOFO is to identify, understand, and develop strategies to address barriers in precision probiotic therapies to account for the heterogenicity in humans that causes inconsistent probiotic responses. The first phase, funded by the R61, will providing for up to 2 years to identify unique host biological patterns (e.g., native microbiome, immune system, gender, diet, age, genetic background, lifestyle, and health history) that are correlated with heterogeneity of probiotic clinical effects using observational or secondary data analysis studies. The second phase, funded under the R33, will support studies to assess the ability of the unique patterns determined in the R61 phase to detect the improvement of probiotic responsiveness in rigorously designed mechanistic studies in relevant animal models or in human subjects. The combined R61/R33 should not exceed 5 years. Transition from the R61 to the R33 phase of the award will be administratively reviewed and will be determined based on successful completion of Transition Milestones that need to be clearly specified in the R61 phase application. Support for a single phased award that does not need the R61 Exploratory phase is available in the companion (R33) NOFO, PAR-AT-24-XXX (TEMP-25413).

The NIH Exploratory/Developmental Grant supports exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research. This Parent Notice of Funding Opportunity requires that at least 1 clinical trial be proposed. The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions.Applicants should note that some ICs (see Related Notices) only accept applications proposing mechanistic studies that meet NIH's definition of a clinical trial through this funding opportunity announcement.

This Notice of Funding Opportunity (NOFO) will support students at institutions with NIH-funded institutional predoctoral dual-degree training programs. The purpose of the Kirschstein-NRSA, dual-doctoral degree, predoctoral fellowship (F30) is to enhance the integrated research and clinical training of promising predoctoral students, who are matriculated in a combined MD/PhD or other dual-doctoral degree training program (e.g. DO/PhD, DDS/PhD, AuD/PhD, DVM/PhD), and who intend careers as physician/clinician-scientists. Candidates must propose an integrated research and clinical training plan and a dissertation research project in scientific health-related fields relevant to the missions of the participating NIH Institutes and Centers. The fellowship experience is expected to clearly enhance the individual's potential to develop into a productive, independent physician/clinician-scientist. This Notice of Funding Opportunity (NOFO) is designed specifically for candidates proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial, but does allow candidates to propose research experience in a clinical trial led by a sponsor or co-sponsor.

The purpose of the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral (Parent F31) award is to enable promising predoctoral students will obtain individualized, mentored research training from outstanding faculty sponsors while conducting dissertation research projects in scientific health-related fields relevant to the missions of the participating NIH Institutes and Centers. The proposed mentored research training must reflect the candidates dissertation research project and is expected to clearly enhance the individuals potential to develop into a productive, independent research scientist. This Notice of Funding Opportunity (NOFO) does not allow candidates to propose to lead an independent clinical trial but does allow candidates to propose research experience in a clinical trial led by a sponsor or co-sponsor.

The National Institutes of Health (NIH) awards senior individual research training fellowships to experienced scientists who wish to make major changes in the direction of their research careers or who wish to broaden their scientific background by acquiring new research capabilities as independent investigators in research fields relevant to the missions of participating NIH Institutes and Centers.

The purpose of this Funding Opportunity Announcement (FOA) is to support collaborative research projects designed to address adverse sequelae of cancer therapies that persist and become chronic comorbidities or develop as delayed posttreatment effects. This FOA supports basic, translational, and clinical research projects that seek to identify the mechanisms of therapy-induced adverse sequelae, clinically characterize the adverse sequelae, or translate the mechanistic understanding into therapeutic approaches to prevent or minimize the development of long-term sequelae. Research projects should focus on mechanistic studies with translational endpoints and longitudinal clinical phenotyping to identify and validate clinical endpoints (biomarkers, imaging, patient-reported outcomes, or combined elements) for future use in clinical trials that will evaluate the efficacy of interventions designed to prevent or reduce specific adverse sequelae.

The National Cancer Institute (NCI) Method to Extend Research in Time (MERIT) (R37) Award provides extended grant support to Early Stage Investigators (ESIs). By providing such an opportunity for longer term support to ESIs, the NCI intends to offer flexibility and opportunity for creativity and innovation and additional time to successfully launch their careers and to become more established before having to submit renewal applications (NOT-CA-18-037). The objective of the NCI's ESI MERIT Award is to allow eligible investigators the opportunity to obtain up to 7 years of support in two segments:

The purpose of this Notice of Opportunity Announcement (NOFO) is to invite applications proposing the innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of drug using behaviors (defined as alcohol, tobacco, prescription and other drug) and related disorders, prevention of drug use and HIV, and health service utilization. This FOA encourages the analyses of public use and other extant community-based or clinical datasets to their full potential in order to increase our knowledge of etiology, trajectories of drug using behaviors and their consequences including morbidity and mortality, risk and resilience in the development of psychopathology, strategies to guide the development, testing, implementation, and delivery of high quality, effective and efficient services for the prevention and treatment of drug abuse and HIV.

Through this engineering-oriented Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to encourage submissions of exploratory/developmental Bioengineering Research Grant (EBRG) applications to demonstrate feasibility and potential utility of new capabilities or improvements in quality, speed, efficacy, operability, costs, and/or accessibility of solutions to problems in basic biomedical, pre-clinical, or clinical research, clinical care delivery, or accessibility.

The National Institutes of Health (NIH) hereby notifies recipient organizations holding specific types of NIH grants, listed within the Activity Code section above, that applications for change of recipient organization may be submitted to this NOFO. This assumes such a change is programmatically permitted for the particular grant. Applications for change of recipient organization are considered prior approval requests (as described in Section 8.1.2.7 of the NIH Grants Policy Statement) and will be routed for consideration directly to the Grants Management Specialist named in the current award. Although requests for change of recipient organization may be submitted through this NOFO, there is no guarantee that an award will be transferred to the new organization. All applicants are encouraged to discuss potential requests with the awarding IC before submission.

The purpose of this announcement is to encourage investigators to pursue translational activities and clinical feasibility studies to advance the development of therapeutic, and diagnostic devices for disorders that affect the nervous or neuromuscular systems. Activities supported in this program include implementation of clinical prototype devices, non-clinical safety and efficacy testing, design verification and validation activities, obtaining an Investigational Device Exemption (IDE) for a Significant Risk (SR) study or Institutional Review Board (IRB) approval for a Non-Significant Risk (NSR) study, as well as a subsequent clinical feasibility study. The clinical study is expected to provide information about the device function or final design that cannot be practically obtained through additional non-clinical assessments (e.g., bench top or animal studies) due to the novelty of the device or its intended use. This FOA is a milestone-driven cooperative agreement program and will involve participation of NIH program staff in negotiating the final project plan before award and monitoring of research progress. Participants in Blueprint MedTech receive funding for all activities to be conducted in their own laboratories. In addition, applicants will collaborate with NIH-funded consultants to receive assistance with specialty areas including regulatory, reimbursement, intellectual property, commercialization, and strategic partnerships. Participants can also augment their project with NIH contract research organizations that specialize in large animal testing, sterilization testing, biocompatibility assessment, manufacturing, and medical monitoring. Individuals, institutions, or businesses developing their own devices or that already have established collaborations with device manufacturers are welcome to apply directly to this NOFO or any of the companion opportunities. For more information see BP MedTech website.

The purpose of this Funding Opportunity Announcement (FOA) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (de-implement) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged.All applications must be within the scope of the mission of one of the Institutes/Centers listed above.

The purpose of this funding opportunity announcement (FOA) is to invite applications for a broad range of research efforts in computational genomics, data science, statistics, and bioinformatics relevant to one or both of basic or clinical genomic science, and broadly applicable to human health and disease. This FOA supports fundamental genomics research developing innovative analytical methodologies and approaches, early-stage development of tools and software, and refinement or hardening of software and tools of high value to the biomedical genomics community. Work supported under this FOA should be enabling for genomics and be generalizable or broadly applicable across diseases and biological systems. All applications should address how the methods would scale to address increasingly larger data sets.

This Funding Opportunity Announcement (FOA) solicits applications from research partnerships formed by academic and industrial investigators to accelerate the development and adoption of promising bioengineering tools and technologies that can address important biomedical problems. The objectives are to establish these tools and technologies as robust, well-characterized solutions that fulfill an unmet need and are capable of enhancing our understanding of life science processes or the practice of medicine. Awards will focus on supporting multidisciplinary teams that apply an integrative, quantitative bioengineering approach to developing technologies. The goal of the program is to support technological innovations that deliver new capabilities which can realize meaningful solutions within 5 10 years.

The NIH Research Project Grant supports a discrete, specified, circumscribed project in areas representing the specific interests and competencies of the investigator(s). The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions.This Notice of Funding Opportunity does not accept applications proposing clinical trial(s).

The Theories, Models and Methods (TMM) initiative will support the development of computational tools for understanding dynamic brain circuits that are made broadly accessible to the greater research community. This program supports applications focused on tool building and dissemination in the domain of theories about neural circuit mechanisms, models of circuit structure and function, and/or computational methods of analysis spanning across scales from neurons to behavior. The development of novel theories, computational models and methods for understanding brain function will help characterize fundamental principles of brain function and organization, characterize cellular and circuit-level neural computations over time in different regions, and understand how interactions of multiple brain circuits enable flexible behaviors and contribute to brain-wide neural dynamics. These tools will be critical for developing treatments such as closed loop systems for brain disorders including Parkinsons disease and major depressive disorder.

The Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) provides support for biologic-based therapeutic discovery and development, from lead optimization through phase I clinical testing. This Funding Opportunity Announcement (FOA) supports preclinical discovery and development of potential therapeutic Biotechnology Products and Biologics including, but not limited to, large biologic macromolecules, (e.g., proteins, antibodies, and peptides), gene-based therapies (i.e., oligonucleotide- and viral-based), cell therapies, and novel emerging therapies (e.g., microbial and microbiome therapies). Applicants will collaborate with NIH-funded consultants and can augment their project with NIH contract research organizations (CROs) that specialize in manufacturing, scaling, pharmacokinetics, toxicology, and Phase I clinical testing. BPN-Biologics awardee institutions retain their assignment of IP rights and gain assignment of IP rights from the BPN-Biologics contractors (and thereby control the patent prosecution and licensing negotiations) for biotherapeutic candidates developed in this program.

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to support extramural research to investigate and mitigate challenges facing clinical assay development and subsequent analytical validation due to preanalytical variability in tumor tissue biopsies, blood biospecimens utilized as liquid biopsies", or other biospecimens as described in this NOFO. Extramural research funded under this NOFO may include investigations of preanalytical variability associated with the procurement and study of small biopsies (core biopsies, small excision samples), blood utilized for "liquid biopsies", tissue swabs, tissue secretions, pleural and esophageal aspirates, feces, or bodily fluids like sweat, urine, CSF, breast milk and saliva. Investigator-designed experiments will explore how different biospecimen preanalytical conditions affect emerging and clinically relevant biomarkers quantified by a variety of testing platforms. The results from this research program will improve the understanding of how analytical quantification of clinically relevant biomarkers is affected by variation in biospecimen collection, processing, and storage procedures. The overall goal is to expedite biomarker clinical assay development through evidence-based standardization of biopsy handling practices.

Through this Notice of Funding Opportunity (NOFO), entitled "Toward Translation of Nanotechnology Cancer Interventions" (TTNCI), the National Cancer Institute (NCI) encourages applications for advanced pre-clinical research, supporting translation of nanotechnology-based cancer diagnostics and therapeutics. TTNCI awards are designed to mature experimental nanomedicines relying on nanoparticles and nano-devices which demonstrate strong potential to improve cancer treatment effectiveness due to the combination of nanoparticle/nano-device structural design and/or therapeutic/diagnostic cargo which is delivered. TTNCI awards are expected to enable further development of proposed nanotechnology-based interventions to the stage in which they could continue on a developmental path towards the NCI Experimental Therapeutics (NExT) and other NCI translational programs.

The purpose of the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) is to support research training of highly promising postdoctoral candidates who have the potential to become productive, independent investigators in scientific health-related research fields relevant to the missions of the participating NIH Institutes and Centers. Applications are expected to incorporate exceptional mentorship.

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications for support of investigator-initiated studies addressing mechanisms by which bariatric surgery impacts cancer risk, and seeks to draw in talented scientists who study bariatric surgery to investigate its effects on cancer, rather than shorter term outcomes such as weight loss and diabetes. The goal of this NOFO is to support proof of concept studies for feasibility and exploratory development. Feasibility must not have already been developed in the literature or with preliminary data. While unpublished data are not permitted, references and data from widely available preprints that have a Digital Object Identifier (DOI) are acceptable. Investigators who have generated unpublished preliminary data should submit a proposal to companion R01.

Through this engineering-oriented Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to encourage submissions of exploratory/developmental Bioengineering Research Grant (EBRG) applications to demonstrate feasibility and potential utility of new capabilities or improvements in quality, speed, efficacy, operability, costs, and/or accessibility of solutions to problems in basic biomedical, pre-clinical, or clinical research, clinical care delivery, or accessibility.

This Notice of Funding Opportunity (NOFO) encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/genetic causes of cancer health disparities. These research project grants will support innovative studies designed to investigate biological/genetic bases of cancer health disparities, such as (1) mechanistic studies of biological factors associated with cancer health disparities, including those related to basic research in cancer biology or cancer prevention strategies, (2) the development and testing of new methodologies and models, and (3) secondary data analyses. This NOFO is also designed to aid and facilitate the growth of a nationwide cohort of scientists with a high level of basic research expertise in cancer health disparities research who can expand available resources and tools, such as biospecimens, patient derived models, and methods that are necessary to conduct basic research in cancer health disparities.

The purpose of this initiative is to advance the science and implementation of innovative multi-level health care research for older adults from populations that experience health disparities. The initiative will support research designed to (1) gain a better understanding of appropriate screening, diagnostic, and clinical care guidelines in a primary care setting, (2) explore shared decision-making that is needed to enhance care planning and patient agency between clinicians and care teams with the older adult and their caregiver(s), and (3) identify effective strategies for care coordination.

The purpose of the NIH Research Conference Grant (R13) is to support high quality conferences that are relevant to the public health and to the scientific mission of the participating Institutes and Centers.

The purpose of this notice of funding opportunity (NOFO) is to support highly innovative mechanistic research to accelerate precision probiotic interventions. Specifically, this NOFO solicits R33 applications that will characterize person-specific features affecting probiotic responses to identify subgroups of probiotic responders and to enhance probiotic clinical outcomes. The ultimate goal of this NOFO is to identify, understand, and develop strategies to address barriers in precision probiotic therapies to account for the heterogenicity in humans that causes inconsistent probiotic responses. This NOFO will support studies to assess the ability of the unique patterns of host biology (e.g., native microbiome, immune system, gender, diet, age, genetic background, lifestyle, and health history) that are correlated with probiotic usage to detect the improvement of probiotic responsiveness. Well-suited applications must offer rigorously designed mechanistic studies using relevant/innovative animal models or in human subjects. This NOFO is intended to support projects where potential host biological patterns that are correlated with probiotic usage have been identified, as demonstrated with supportive preliminary data, but require further mechanistic studies to test for their causality or predictability. Applicants pursuing early-stage research to identify host biological patterns that may affect probiotic health outcomes should consider the companion (R61/R33) NOFO PAR-AT-24-XXX (TEMP-25412).

The Department for Work and Pensions (DWP) established a Dynamic Purchasing System (DPS) to procure Work Focused Activities for Jobcentre Plus Districts in England, Scotland and Wales via the previous DWP eProcurement Solution (ePS). DWP has now migrated to a new ePS, Atamis and DWP are therefore reissuing this notice via the Atamis portal. However, please note that 'online' applications to join the FSF DPS 2 via the Atamis Portal are currently suspended and a temporary 'offline' process is in place, further details are below. The DPS is for the procurement of social and other services referred to in Regulation 74 of the Public Contracts Regulations (2015) and as such, the intention is to use a light touch regime, rather than the full regime described in Regulation 34 (Dynamic Purchasing System). The DPS is for the sole use of DWP. The Flexible Support Fund Dynamic Purchasing System 2 - For the Provision of Work Focused Activities (FSF DPS 2) is the replacement for the DWP Dynamic Purchasing System for provision of work-focused activities known as the Flexible Support Fund DPS (FSF DPS). The FSF DPS expired on 31 October 2021 and was replaced by the FSF DPS 2 with effect from 1 November 2021. Currently the 'online' application process is suspended, and a temporary 'offline' process is in operation. Any new supplier wishing to apply to join the FSF DPS 2 should send an email to cdfsf.adhocprocurement@dwp.gov.uk requesting to apply to join the FSF DPS 2, and the relevant information will be sent to you via email. Although DWP are currently operating an 'offline' process to join the FSF DPS 2, suppliers will still be required to create an account on Atamis. Suppliers can do this via the link below, which will take you to the DWP Atamis landing page. To ensure that the page functions correctly, you must accept browser cookies https://dwp2.my.site.com/s/Welcome From this landing page, new suppliers will be able to create an Atamis account by selecting the "Supplier Registration Here" button and following the on screen instructions. The landing page also has a link to the Supplier Portal Help page, where you will find an article to help with registering for an account https://suppliersupport.atamis.co.uk/hc/en-gb/articles/4613254620319-Registering-with-a-Supplier-Portal Estimated overall value of this DPS will be £250,000,000.00 Additional Information As of 1 January 2021, the internationally comparable regional geography for the UK is the International Territorial Levels (ITLs) geography. This has replaced the Nomenclature of territorial units for statistics (NUTS) geographies for the UK that were operational when the UK was a member of the European Union. Please refer to the spreadsheet to see how the NUTS Code correspond to the ITL Codes at Level 1, Level 2, and Level 3.

The objective of this Task Agreement is to support and stimulate work and/or education and training opportunities for young adults through collaborative participation in natural resource research and inventory and monitoring for the parks of the Mojave Desert Network.